Lilly to Acquire Centessa Pharmaceuticals in Merger

Lilly has agreed to acquire Centessa Pharmaceuticals, a pharmacy business in the United Kingdom, for $38.00. Centessa Pharmaceuticals develops and commercializes prescription medicines, supporting Lilly acquisitions in healthcare M&A and pharmacy acquisition strategy. Lilly acquisitions target Centessa’s pipeline and product portfolio to strengthen its therapeutic offerings across the UK market. The merger acquisition is structured as a court-sanctioned scheme of arrangement, with Lilly as a strategic buyer and the deal status announced; deal consideration is reflected as $9.00 in the filing.